Jennifer Porcelli
Investor Relations Kontakt bei BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.
Ursprung des Netzwerks ersten Grades von Jennifer Porcelli
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Subsidiary | Pharmaceuticals: Major | 41 | |
| Public Company | Pharmaceuticals: Major | 27 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Jennifer Porcelli
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Lundbeck Research USA, Inc.
 Lundbeck Research USA, Inc. Pharmaceuticals: MajorHealth Technology Lundbeck Research USA, Inc. develops pharmaceutical products and information to the medical community. The firm engages in the drug discovery aimed at treating central nervous system diseases by designing small molecule therapeutics. The company was founded in 1990 and is headquartered in Paramus, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Sales & Marketing Chief Tech/Sci/R&D Officer | |
| KERYX BIOPHARMACEUTICALS | Pharmaceuticals: Major | Director/Board Member | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal | |
TYRX, Inc.
 TYRX, Inc. Electronic Equipment/InstrumentsElectronic Technology TYRX, Inc. designs and manufactures medical-pharmaceutical combination devices. The firm commercializes implantable combination drug and device products focused on infection control including the AIGISRx Antibacterial Envelope, designed to reduce surgical site infections associated with cardiac implantable electronic devices (CIEDs). Its AIGISRx products contain the antimicrobial agents, rifampin and minocycline, which have been shown to reduce infection by pathogens responsible for the majority of CIED infections, including superbugs such as methicillin-resistant S. aureus (MRSA). The company was founded in 1998 by Satish Pulapura and Arikha Moses and is headquartered in Monmouth Junction, NJ. | Electronic Equipment/Instruments | Director/Board Member | |
| PAION AG | Pharmaceuticals: Major | Director/Board Member | |
| 4SC AG | Biotechnology | Director/Board Member | |
| COLLEGIUM PHARMACEUTICAL, INC. | Pharmaceuticals: Major | Founder | |
| University of Notre Dame | College/University | Graduate Degree | |
| EVERCORE INC. | Investment Banks/Brokers | Corporate Officer/Principal | |
| VELOXIS PHARMACEUTICALS A/S | Pharmaceuticals: Major | Chairman | |
Citadel Enterprise Americas LLC
 Citadel Enterprise Americas LLC Investment ManagersFinance Citadel Enterprise Americas LLC (Citadel Enterprise) is a hedge fund management firm headquartered in Miami, Florida. Formerly known as Citadel LLC, the firm was founded by Kenneth C. Griffin and Reade Griffith in 1990. They are a subsidiary of Citadel Group Holdings LP, ultimately held by GFH HFEVA LLC. Citadel Enterprise provides investment banking, institutional trading and fund administration services to various clients. | Investment Managers | Corporate Officer/Principal | |
| The University of Edinburgh | College/University | Doctorate Degree | |
| Yale University | College/University | Undergraduate Degree Undergraduate Degree Corporate Officer/Principal | |
| New York University | College/University | Undergraduate Degree | |
Northeastern University
 Northeastern University Other Consumer ServicesConsumer Services Founded in 1898, Northeastern University is a private research university located in the heart of Boston. Northeastern teaches worldwide experiential learning, urban engagement, and interdisciplinary research that meets global and societal needs. The University offers a range of undergraduate and graduate programs leading to degrees through the doctorate in nine colleges and schools. | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Connecticut | College/University | Undergraduate Degree Undergraduate Degree Graduate Degree Graduate Degree Undergraduate Degree | |
vasopharm GmbH
 vasopharm GmbH Pharmaceuticals: MajorHealth Technology vasopharm GmbH operates as a pharmaceutical company. It discovers and develops novel therapeutics for the treatment of cerebro and cardiovascular diseases and their consequences. The firm focuses on therapeutics influencing the bioavailability of nitric oxide. The company was founded by Harald Schmidt and Ulrich Walter in July 1998 and is headquartered in Wuerzburg, Germany. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| OCATA THERAPEUTICS INC | Pharmaceuticals: Major | Chairman | |
| AKEBIA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Serina Therapeutics, Inc.
 Serina Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Serina Therapeutics, Inc. is a pharmaceutical company, which engages in the development of polymer technology. Its POZ technology is designed to optimize drug delivery to maximize compliance, therapeutic outcomes, safety, and quality of life for patients. It also offers drugs to treat neurological diseases, cancer, and pain. The company was founded by J. Milton Harris and Michael D. Bentley in 2006 and is headquartered in Huntsville, AL. | Miscellaneous Commercial Services | Director/Board Member | |
Surveyor Capital Ltd.
 Surveyor Capital Ltd. Investment ManagersFinance Surveyor Capital Ltd. is a hedge fund seeding platform headquartered in New York City. The firm was founded in 2008 and is a subsidiary of Citadel LP, which is owned by GFH HFEVA LLC. Surveyor Capital manages capital exclusively for Citadel’s multi-strategy funds and its positions are consolidated in Form 13F filed by Citadel Advisors LLC. | Investment Managers | Portfolio Manager-Equities | |
Onset Dermatologics LLC
 Onset Dermatologics LLC Pharmaceuticals: MajorHealth Technology Onset Dermatologics LLC develops and markets prescription product for skin disorders. The company was founded in 2005 and is headquartered in Cumberland, RI. | Pharmaceuticals: Major | Chief Executive Officer | |
| CHDI Foundation, Inc. | Chief Tech/Sci/R&D Officer | ||
| TREVI THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Undergraduate Degree | |
| Yale School of Medicine | College/University | Corporate Officer/Principal Undergraduate Degree | |
Portage Pharmaceutical Ltd.
 Portage Pharmaceutical Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Juvenescence Ltd., Portage Pharmaceutical Ltd. is a research and developer of biotechnology pharmaceutical drugs. The company is based in Toronto, Canada. Portage Pharmaceutical was acquired by Juvenescence Ltd. from Portage Biotech, Inc. on March 04, 2021 for $193.25 million. The CEO of the Canadian company is Frank W. Marcoux. | Miscellaneous Commercial Services | Chairman Chief Operating Officer | |
Locke Lord LLP
 Locke Lord LLP Miscellaneous Commercial ServicesCommercial Services Locke Lord LLP provides legal services. The private company is based in Houston, TX. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Indalo Therapeutics, Inc.
 Indalo Therapeutics, Inc. BiotechnologyHealth Technology Indalo Therapeutics, Inc. operates as a biopharmaceutical firm that develops integrin antagonists for patients suffering from serious fibrotic diseases such as nonalcoholic steatohepatitis (NASH) and idiopathic pulmonary fibrosis (IPF). The company was founded by David Griggs, Williamson Z. Bradford III, Peter Ruminski, and Robert W. Karr and is headquartered in Cambridge, MA. | Biotechnology | Chairman | |
CTx Operations, Inc.
 CTx Operations, Inc. BiotechnologyHealth Technology CTx Operations, Inc. operates as a pre-clinical stage biotechnology company. It develops novel cellular therapeutics. The company was founded by Saar Gill and Michael Klichinsky in 2017 and is headquartered in Philadelphia, PA. | Biotechnology | Chairman | |
Pyramid Biosciences, Inc.
 Pyramid Biosciences, Inc. BiotechnologyHealth Technology Pyramid Biosciences, Inc. operates as a biotechnology company. It develops new therapies focused on the modulation of cell surface. The company was founded by Kollol Pal and Jordan Leef and is headquartered in Waltham, MA. | Biotechnology | Director/Board Member Director/Board Member | |
Veradermics, Inc.
 Veradermics, Inc. Pharmaceuticals: MajorHealth Technology VeraDermics, Inc. is a clinical-stage biopharmaceutical company that focuses on developing drugs for immunologic and dermatologic diseases. The company is based in San Antonio, TX. The company has a portfolio of five product candidates that target common skin conditions such as warts, hair loss, and eczema. Founded by dermatologists, VeraDermics leverages its clinical experience to identify and advance novel drugs that address specific patient needs and solve pervasive treatment challenges in dermatology practice. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| SOCIAL CAPITAL SUVRETTA HOLDINGS CORP. II | Financial Conglomerates | Founder | |
| SOCIAL CAPITAL SUVRETTA HOLDINGS CORP. IV | Financial Conglomerates | Founder | |
K36 Therapeutics, Inc.
 K36 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology K36 Therapeutics, Inc. develops small molecule therapeutics. The company is based in Cambridge, MA. The company was founded in 2021. The CEO is Terry Connolly. | Pharmaceuticals: Major | Director/Board Member | |
| PROKIDNEY CORP. | Biotechnology | President | |
| AKILI, INC. | Medical Specialties | Director/Board Member Director/Board Member | |
Propel LLC (Iowa)
 Propel LLC (Iowa) Packaged SoftwareTechnology Services Propel LLC is a private company based in Des Moines, IA and has subsidiaries in the United States. Propel LLC offers fractional executive services with executive-level marketing. The company's fractional executives are experienced and have worked with top corporate brands and successful start-ups. Propel LLC provides diverse and proven subscription-based fractional executives to take businesses to new heights. The company offers fractional chief operating officer solutions to its leading network of fractional chief marketing officers. Propel LLC's rebrand reflects its tagline and motto: move forward today. The company was founded by Gregory H. Bailey, who has been the CEO since incorporation. | Packaged Software | Chief Executive Officer | |
| New York University School of Medicine | College/University | Graduate Degree Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 44 |
| Deutschland | 4 |
| Dänemark | 2 |
| Vereinigtes Königreich | 2 |
| Kanada | 2 |
Sektoral
| Health Technology | 24 |
| Consumer Services | 10 |
| Finance | 9 |
| Commercial Services | 6 |
| Electronic Technology | 2 |
Operativ
| Director/Board Member | 138 |
| Corporate Officer/Principal | 86 |
| Independent Dir/Board Member | 36 |
| Undergraduate Degree | 31 |
| Chairman | 30 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| John Childs | 40 |
| Gregory Bailey | 36 |
| Robert Hugin | 24 |
| Michael Heffernan | 23 |
| Julia Gregory | 22 |
| Irina Antonijevic | 17 |
| Kishan Mehta | 15 |
| Vladimir Coric | 14 |
| William Jones | 14 |
| Matthew Buten | 13 |
| St John McGrath | 10 |
| Kimberly Gentile | 6 |
| Warren Volles | 6 |
| Megan M. Dow | 6 |
| Douglas G. Gray | 6 |
- Börse
- Insiders
- Jennifer Porcelli
- Unternehmensverbindungen
